Implementation of PHQ-9 Depression Screening for HIV-Infected Patients in a Real-World Setting

被引:17
|
作者
Edwards, Malaika [1 ]
Quinlivan, Evelyn Byrd [1 ]
Bess, Kiana [2 ]
Gaynes, Bradley N. [3 ]
Heine, Amy [4 ]
Zinski, Anne [5 ]
Modi, Riddhi [5 ]
Pence, Brian W. [6 ]
机构
[1] Univ N Carolina, Infect Dis Clin, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27514 USA
[2] Duke Univ, Infect Dis Clin, Durham, NC USA
[3] Univ N Carolina, Dept Psychiat, Psychiat Outpatient Serv, Chapel Hill, NC USA
[4] Univ N Carolina, Infect Dis Clin, Chapel Hill, NC USA
[5] Univ Alabama Birmingham, Sch Med, Div Infect Dis, Birmingham, AL USA
[6] Duke Univ, Durham, NC USA
来源
JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE | 2014年 / 25卷 / 03期
基金
美国国家卫生研究院;
关键词
depression; HIV; infectious diseases; PHQ-9; screening; ACTIVE ANTIRETROVIRAL THERAPY; MENTAL-ILLNESS; SUBSTANCE-ABUSE; UNITED-STATES; CARE; ROUTINE; PREVALENCE; DISORDERS; SYMPTOMS;
D O I
10.1016/j.jana.2013.05.004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The prevalence of depression is 20%-30% for people living with HIV, and while it is associated with poorer adherence to antiretrovirals, it is often unrecognized by medical providers. Although it has been challenging for some health care settings to develop consistent depression screening mechanisms, it is feasible to create screening protocols using the nine-item Patient Health Questionnaire (PHQ-9). Establishing a depression screening and response protocol is an iterative process that involves preparing staff, determining screening frequency, and developing procedures for response and appropriate medical record documentation. While there are multiple issues and potential challenges during implementation, it is possible to incorporate systematic depression screening into HIV primary care in a manner that achieves staff buy-in, minimizes patient burden, streamlines communication, and efficiently uses the resources available in the medical setting.
引用
收藏
页码:243 / 252
页数:10
相关论文
共 50 条
  • [31] The validity and reliability of the PHQ-9 on screening of depression in neurology: a cross sectional study
    Yajing Sun
    Zhifei Kong
    Yuqing Song
    Jing Liu
    Xilin Wang
    BMC Psychiatry, 22
  • [32] Screening for depression as part of annual diabetic review using PHQ-9 scores: a pilot study
    Asim, Rabeeah
    Asim, Muhammad
    Reddy, Rajah
    Chepulis, Lynne
    Lawrenson, Ross
    PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT, 2023, 24
  • [33] Assessment of depression severity with the PHQ-9 in cancer patients and in the general population
    Andreas Hinz
    Anja Mehnert
    Rüya-Daniela Kocalevent
    Elmar Brähler
    Thomas Forkmann
    Susanne Singer
    Thomas Schulte
    BMC Psychiatry, 16
  • [34] Screening Utility of the PHQ-2 and PHQ-9 for Depression in College Students: Relationships with Substantive Scales of the MMPI-3
    Morris, Nicole M.
    Ingram, Paul B.
    Mitchell, Sean M.
    Victor, Sarah E.
    MEASUREMENT AND EVALUATION IN COUNSELING AND DEVELOPMENT, 2023, 56 (03) : 254 - 264
  • [35] Comparing the factor structures and reliabilities of the EPDS and the PHQ-9 for screening antepartum and postpartum depression: a multigroup confirmatory factor analysis
    Stefana, Alberto
    Langfus, Joshua A.
    Palumbo, Gabriella
    Cena, Loredana
    Trainini, Alice
    Gigantesco, Antonella
    Mirabella, Fiorino
    ARCHIVES OF WOMENS MENTAL HEALTH, 2023, 26 (05) : 659 - 668
  • [36] A Brief Depression Screening Tool for Perinatal Clinical Practice: The Performance of the PHQ-2 Compared with the PHQ-9
    Gigantesco, Antonella
    Palumbo, Gabriella
    Cena, Loredana
    Camoni, Laura
    Trainini, Alice
    Stefana, Alberto
    Mirabella, Fiorino
    JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2022, 67 (05) : 586 - 592
  • [37] Estimation of depression prevalence in patients with Stargardt disease using PHQ-9 and Zung scores
    Moschos, Marilita M.
    Nitoda, Eirini
    Lavaris, Anastasios
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2016, 26 (03) : 268 - 272
  • [38] Implementation and Operational Research: Use of Symptom Screening and Sputum Microscopy Testing for Active Tuberculosis Case Detection Among HIV-Infected Patients in Real-World Clinical Practice in Uganda
    Roy, Monika
    Muyindike, Winnie
    Vijayan, Tara
    Kanyesigye, Michael
    Bwana, Mwebesa
    Wenger, Megan
    Martin, Jeffrey
    Geng, Elvin
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 72 (05) : e86 - e91
  • [39] People with diabetes need a lower cut-off than others for depression screening with PHQ-9
    Cichon, Ewelina
    Kiejna, Andrzej
    Kokoszka, Andrzej
    Gondek, Tomasz M.
    Radzio, Rafal
    Jastrzebski, Adam
    Andrzejewska, Beata E.
    Alosaimi, Fahad D.
    Lloyd, Cathy E.
    Sartorius, Norman
    PLOS ONE, 2020, 15 (10):
  • [40] Screening for depression: Rasch analysis of the dimensional structure of the PHQ-9 and the HADS-D
    Kendel, Friederike
    Wirtz, Markus
    Dunkel, Anne
    Lehmkuhl, Elke
    Hetzer, Roland
    Regitz-Zagrosek, Vera
    JOURNAL OF AFFECTIVE DISORDERS, 2010, 122 (03) : 241 - 246